Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral anticoagulation: challenges in the case-management setting.

Sandra Lowery1, Kathleen Haley, Henry I Bussey

  • 1University Systems of New Hampshire, USA. ccmi@lowery.mv.com

Lippincott'S Case Management : Managing the Process of Patient Care
|February 3, 2005
PubMed
Summary

Case managers are vital for preventing thromboembolic disorders, but warfarin has limitations. New anticoagulants like ximelagatran offer potential improvements for patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Intrauterine Smoke Exposure on microRNA-15a Expression in Human Lung Development and Subsequent Asthma Risk.

Healthcare (Basel, Switzerland)·2020
Same author

Antigen nature and complexity influence human antibody light chain usage and specificity.

Vaccine·2016
Same author

Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2015
Same author

Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.

Pharmacotherapy·2013
Same author

Impact of a new method of warfarin management on patient satisfaction, time, and cost.

Pharmacotherapy·2013
Same author

Cardiology patient page. Warfarin management: international normalized ratio self-testing and warfarin self-dosing.

Circulation·2012

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Patient Management

Background:

  • Thromboembolic events like stroke and deep-vein thrombosis cause significant morbidity and mortality.
  • Oral warfarin is a primary anticoagulant but has limitations including a narrow therapeutic window, frequent monitoring needs, and drug/food interactions.
  • Effective alternatives to warfarin are needed, especially for high-risk populations.

Purpose of the Study:

  • To review the role of case managers in managing thromboembolic disorders.
  • To discuss the limitations of warfarin therapy.
  • To explore potential benefits of newer oral anticoagulants, such as ximelagatran.

Main Methods:

  • Literature review on thromboembolic disorder management.
  • Analysis of warfarin's efficacy, safety, and limitations.

Related Experiment Videos

  • Evaluation of emerging anticoagulants, focusing on ximelagatran's profile.

    • Main Results:

    • Warfarin requires intensive monitoring (international normalized ratio) to maintain efficacy and safety, which is often challenging.
    • Ximelagatran, an oral direct thrombin inhibitor, shows promise with a wider therapeutic window and fewer interactions, but has potential liver enzyme issues.
    • Case managers can play a key role in optimizing treatment and improving outcomes with new anticoagulants.

    Conclusions:

    • Improved anticoagulation strategies are essential for reducing thromboembolic event burden.
    • Ximelagatran presents a potentially favorable alternative to warfarin, pending FDA approval and further safety data.
    • Case management integration with novel anticoagulants may enhance patient care and outcomes.